Kristelle Lusby, MD
Plastic and Reconstructive Surgery · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 7 carriers
- Office
- 1
Offices
1 location
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
23 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lusby’s office at (408) 396-1115 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A107784 · Current
Licensed to practise in California · since 2009 · expires 2026-11-30 · Eastern Virginia Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Los Gatos Surgical CenterAmbulatory Surgery Center · Los Gatos, CA0.1% owner since 2024 · accredited by AAAHCAccreditation Renewed6 inspections, 3 with deficiencies · last 2025-04-03
- Los Gatos Surgical CenterSan Jose, CA0.1% owner since 2024 · accredited by AAAHCClosed1 inspection · last 2021-08-10
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$52,770
Medicare paid this office $52,770 for 75 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 31 | $4,202 | $136 |
| Short return visit (20+ min) | 21 | $2,347 | $87 |
| New patient visit (30+ min) | 24 | $2,078 | $87 |
Procedures Medicare counted
| Mastectomy | 1-10 | None |
| Melanoma (skin cancer) excision | 36 | More than 83% of doctors who do this |
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
75 Original Medicare patients in 2024. Average age 76 · Women 52% · Health risk score 0.86. At or below the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: High blood pressure 65% · Cancer 27% · Coronary heart disease 24% · Chronic kidney disease 17% · Diabetes 16% · Atrial fibrillation 15%.
The office billed $278,832, Medicare allowed $68,618 and paid $52,770; for 268 services of 79 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 75 | 268 | 76 | 0.86 | $278,832 | $52,770 |
| 2023 | 79 | 287 | 74 | 0.89 | $129,062 | $57,145 |
| 2022 | 85 | 274 | 76 | 1.23 | $140,249 | $57,947 |
| 2021 | 81 | 238 | 75 | 0.99 | $107,009 | $44,430 |
| 2020 | 82 | 259 | 76 | 1.06 | $103,477 | $47,117 |
| 2019 | 105 | 387 | 76 | 1.17 | $156,480 | $70,315 |
| 2018 | 442 | 770 | 78 | 1.18 | $672,828 | $286,014 |
| 2017 | 214 | 327 | 79 | 1.21 | $357,886 | $140,922 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| New patient visit (45+ min) | 25 | $3,935 | $157 |
| Short return visit (20+ min) | 30 | $3,924 | $82 |
| New patient visit (30+ min) | 28 | $2,733 | $98 |
| Return visit (30+ min) | 11 | $1,405 | $117 |
| Short return visit | 14 | $1,222 | $53 |
2022: 5 services
| New patient visit (45+ min) | 37 | $5,192 | $140 |
| New patient visit (30+ min) | 26 | $2,563 | $99 |
| Short return visit (20+ min) | 20 | $1,944 | $78 |
| Imaging of lymph nodes during surgery | 11 | $1,306 | $119 |
| Short return visit | 16 | $943 | $55 |
2021: 4 services
| New patient visit (30+ min) | 37 | $3,626 | $98 |
| New patient visit (45+ min) | 17 | $2,593 | $153 |
| Short return visit (20+ min) | 16 | $1,873 | $89 |
| Short return visit | 15 | $822 | $48 |
2020: 4 services
| New patient visit (30+ min) | 30 | $3,029 | $101 |
| New patient visit (45+ min) | 15 | $2,349 | $157 |
| Short return visit (20+ min) | 28 | $2,203 | $69 |
| Short return visit | 27 | $1,306 | $40 |
2019: 6 services
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 20 | $7,457 | $373 |
| New patient visit (45+ min) | 40 | $6,015 | $150 |
| Short return visit (20+ min) | 31 | $3,477 | $68 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 12 | $1,928 | $161 |
| Short return visit | 36 | $1,886 | $41 |
| New patient visit (30+ min) | 17 | $1,712 | $101 |
2018: 20 services
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 56 | $37,747 | $662 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 46 | $30,770 | $628 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 97 | $30,647 | $303 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 24 | $20,908 | $721 |
| Repair of wound of scalp, arms, or legs by transferring skin, 10.1-30.0 sq cm | 21 | $16,523 | $718 |
| Repair of wound of scalp, arms, or legs by transferring skin, 10.0 sq cm or less | 27 | $15,781 | $564 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 17 | $14,723 | $866 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 17 | $14,682 | $864 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | 14 | $11,648 | $832 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 34 | $8,570 | $245 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 14 | $6,686 | $446 |
| New patient visit (45+ min) | 37 | $5,647 | $153 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 13 | $5,342 | $382 |
| Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | 12 | $3,936 | $328 |
| New patient visit (30+ min) | 26 | $2,432 | $94 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 11 | $1,621 | $147 |
| Return visit (30+ min) | 11 | $1,192 | $108 |
| Short return visit | 26 | $1,182 | $44 |
| Short return visit (20+ min) | 15 | $1,097 | $69 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $461 | $22 |
2017: 9 services
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 29 | $20,783 | $693 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 30 | $18,179 | $606 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 29 | $16,146 | $538 |
| Repair of wound of scalp, arms, or legs by transferring skin, 10.1-30.0 sq cm | 21 | $14,152 | $674 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 15 | $12,262 | $817 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 30 | $9,043 | $292 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 12 | $8,719 | $727 |
| Repair of wound of scalp, arms, or legs by transferring skin, 10.0 sq cm or less | 15 | $8,051 | $537 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 13 | $3,100 | $221 |
Drugs they prescribed that Part D paid
$1,538
Pharmacies billed $1,538 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 26% of their Part D prescriptions (14 of 55) in 2024. At or below the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 28%.
52 generic and fewer than 11 brand-name prescriptions · $1,538 in drug cost · 11 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 13 | $63 | $5 |
Year by year
| 2024 | 55 | 25 | 26% (14) | None | $1,538 |
| 2023 | 99 | 33 | 27% (27) | None | $2,678 |
| 2022 | 78 | 25 | 31% (24) | None | $1,807 |
| 2021 | 67 | 30 | 34% (23) | None | $872 |
| 2020 | 40 | 13 | None | None | $1,979 |
| 2019 | 41 | 20 | 42% (17) | None | $2,270 |
| 2018 | 180 | 145 | 10% (18) | None | $1,975 |
| 2017 | 130 | 97 | 22% (28) | None | $3,559 |
| 2016 | 25 | 17 | 48% (12) | None | $1,032 |
| 2015 | 23 | 19 | 74% (17) | 0% | $337 |
| 2014 | 72 | 28 | 28% (20) | 28% | $16,430 |
| 2013 | 79 | 31 | 24% (19) | None | $8,143 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Mupirocin | 11 | $155 | $14 |
| Ondansetron Odt | 13 | $147 | $11 |
| Hydrocodone-Acetaminophen | 21 | $90 | $4 |
2022: 2 drugs
| Ondansetron Odt | 15 | $139 | $9 |
| Hydrocodone-Acetaminophen | 19 | $130 | $7 |
2021: 1 drug
| Hydrocodone-Acetaminophen | 19 | $164 | $9 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 13 | $84 | $6 |
2018: 3 drugs
| Cephalexin | 114 | $615 | $5 |
| Doxycycline Hyclate | 16 | $214 | $13 |
| Hydrocodone-Acetaminophen | 12 | $107 | $9 |
2017: 2 drugs
| Cephalexin | 69 | $342 | $5 |
| Hydrocodone-Acetaminophen | 18 | $153 | $9 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 11 | $132 | $12 |
2014: 2 drugs
| Hydrocodone-Acetaminophen | 16 | $283 | $18 |
| Pantoprazole | 12 | $202 | $17 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 17 | $155 | $9 |
Money from drug and device companies
$1,174 in 2025
| 2025 | 7 | 20 | None | $1,174 |
| 2024 | 5 | 10 | None | $259 |
| 2023 | 8 | 18 | None | $940 |
| 2022 | 10 | 52 | None | $3,012 |
| 2021 | 8 | 38 | None | $1,412 |
| 2020 | 7 | 18 | None | $296 |
| 2019 | 5 | 17 | None | $221 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotissue Holdings | None | $838 | 9 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $111 | 1 payment
|
| Abbvie | Botox | $94 | 4 payments
|
| Smith+Nephew | Collagenase Santyl | $61 | 3 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $27 | 1 payment
|
| Revance Therapeutics | None | $25 | 1 payment
|
See all 20 published payments
| Abbvie | Meals · 2025-12-05 | None | $22 |
| Biotissue Holdings | Meals · 2025-10-22 | None | $73 |
| Smith+Nephew | Meals · 2025-10-01 | Collagenase Santyl | $17 |
| Revance Therapeutics | Meals · 2025-09-22 | None | $25 |
| Intuitive Surgical | Meals · 2025-09-09 | Da Vinci Surgical System | $111 |
| Abbvie | Meals · 2025-07-15 | Botox | $25 |
| Vertex Pharmaceuticals | Meals · 2025-07-09 | None | $17 |
| Biotissue Holdings | Meals · 2025-06-27 | None | $40 |
| Biotissue Holdings | Meals · 2025-06-25 | None | $109 |
| Biotissue Holdings | Meals · 2025-06-20 | None | $106 |
| Biotissue Holdings | Meals · 2025-06-08 | None | $139 |
| Biotissue Holdings | Meals · 2025-06-05 | None | $126 |
| Biotissue Holdings | Meals · 2025-05-28 | None | $108 |
| Biotissue Holdings | Meals · 2025-05-14 | None | $129 |
| Abbvie | Meals · 2025-05-01 | Botox | $30 |
| Smith+Nephew | Meals · 2025-04-24 | Collagenase Santyl | $20 |
| Abbvie | Meals · 2025-03-07 | None | $17 |
| Smith+Nephew | Meals · 2025-02-19 | Stravix | $24 |
| Mentor Worldwide | Meals · 2025-02-04 | Mentor Memorygel Resterilizable Gel Sizer | $27 |
| Biotissue Holdings | Meals · 2025-01-29 | None | $8 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $259
| Biotissue Holdings | None | $147 | 5 payments
|
| Abbvie | Botox | $40 | 2 payments
|
| Janssen Biotech | Tremfya | $29 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $25 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $19 | 1 payment
|
2023: $940
| Biotissue Holdings | Neox | $746 | 9 payments
|
| Janssen Biotech | Tremfya | $58 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $36 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $25 | 1 payment
|
| Galderma Laboratories L.P. | None | $24 | 1 payment
|
| Integra LifeSciences | Durasorb Monofilament Mesh | $23 | 1 payment
|
| Ethicon US | Dermabond Prineo | $15 | 1 payment
|
| Smith+Nephew | Grafix Pl | $13 | 1 payment
|
2022: $3,012
| BioTissue Holdings | Neox | $2,601 | 35 payments
|
| Smith+Nephew | Grafix Pl | $125 | 5 payments
|
| LEO Pharma | Adbry | $62 | 3 payments
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $55 | 1 payment
|
| Genzyme | Dupixent | $43 | 2 payments
|
| Janssen Biotech | Tremfya | $30 | 2 payments
|
| Abbvie | Humira | $27 | 1 payment
|
| Allergan | Botox | $26 | 1 payment
|
| Incyte | Opzelura | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $18 | 1 payment
|
2021: $1,412
| Tissuetech | Neox | $685 | 20 payments
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $534 | 7 payments
|
| Regeneron Healthcare Solutions | Dupixent | $49 | 3 payments
|
| Smith+Nephew | Grafix Pl | $47 | 2 payments
|
| Janssen Biotech | Remicade | $34 | 2 payments
|
| LEO Pharma | Enstilar | $31 | 2 payments
|
| AbbVie | Humira | $20 | 1 payment
|
| Galderma Laboratories L.P. | None | $11 | 1 payment
|
2020: $296
| Smith+Nephew | Grafix Pl | $136 | 10 payments
|
| Janssen Biotech | Remicade | $54 | 3 payments
|
| Amgen | Otezla | $32 | 1 payment
|
| Biofrontera | Ameluz | $21 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $19 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $18 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $15 | 1 payment
|
2019: $221
| Novartis Pharmaceuticals | Cosentyx | $149 | 12 payments
|
| Smith+Nephew | Grafix Pl Prime | $32 | 2 payments
|
| Mayne Pharma | Doryx | $16 | 1 payment
|
| Allergan | Botox Cosmetic | $12 | 1 payment
|
| LEO Pharma | Enstilar | $12 | 1 payment
|
Professional record
- NPI
- 1932336278
- Licence
- CA A107784California A107784: Current · expires 2026-11-30
- Trained
- Eastern Virginia Medical School, 2008
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 6399 San Ignacio Ave Ste 120, San Jose, CA, 95119
- NPI first listed
- 2009-06-13
- NPI last updated
- 2024-03-19
- NPI record certified
- 2024-03-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 603 S Knickerbocker Dr, Sunnyvale, CA, 94087